Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Goldsmith

Showing results (231-240 of 749) with videos related to

Pageof 75
Sort By:
Current Heart Failure Reports|November 8, 2013
Vasopressin receptor antagonists: from pivotal trials to current practiceAnkur Kalra, Valmiki Maharaj, Steven R Goldsmith
Progress in Cardiovascular Diseases|March 16, 2010
Congestion as a therapeutic target in acute heart failure syndromesSteven R Goldsmith, Filippo Brandimarte, Mihai Gheorghiade
Expert Opinion on Pharmacotherapy|March 16, 2011
Tolvaptan for the treatment of heart failure: a review of the literatureAndrew Ambrosy, Steven R Goldsmith, Mihai Gheorghiade
The Science of the Total Environment|January 27, 1984
Monitoring of unfavorable reproductive outcome (URO) among occupationally exposed groupsJ R Goldsmith, R Israeli, J Elkins
Public Health Reviews|January 1, 1991
Prospective lung health monitoring in relation to a new power plantA Goren, H Bibi, J R Goldsmith
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|November 15, 2018
Adherence to the Mediterranean diet was positively associated with micronutrient adequacy and negatively associated with dietary energy density among adolescentsW Peng, E M Berry, R Goldsmith
Frontiers of Gastrointestinal Research|January 1, 1979
Gastric cancer incidence: suggestive evidence for persisting effects of experiences during 1940--50 (World War II and Postwar) among Eastern European immigrants to Israel and in Warsaw and rural PolandJ R Goldsmith, R Steinitz, Z Wronkowski
Current Opinion in Oncology|July 26, 2022
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomasScott R Goldsmith, Lawrence Liu, Kevin Shiah
Drugs of Today (Barcelona, Spain : 1998)|November 25, 2021
Isatuximab for the treatment of multiple myelomaS R Goldsmith, L Liu, F Covut
Current Hematologic Malignancy Reports|August 27, 2022
Bispecific Antibodies for the Treatment of Multiple MyelomaScott R Goldsmith, Shawn Streeter, Fahrettin Covut
Pageof 75

Showing results (231-240 of 749) with videos related to

Sort By:
Pageof 75
Current Heart Failure Reports|November 8, 2013
Vasopressin receptor antagonists: from pivotal trials to current practiceAnkur Kalra, Valmiki Maharaj, Steven R Goldsmith
Progress in Cardiovascular Diseases|March 16, 2010
Congestion as a therapeutic target in acute heart failure syndromesSteven R Goldsmith, Filippo Brandimarte, Mihai Gheorghiade
Expert Opinion on Pharmacotherapy|March 16, 2011
Tolvaptan for the treatment of heart failure: a review of the literatureAndrew Ambrosy, Steven R Goldsmith, Mihai Gheorghiade
The Science of the Total Environment|January 27, 1984
Monitoring of unfavorable reproductive outcome (URO) among occupationally exposed groupsJ R Goldsmith, R Israeli, J Elkins
Public Health Reviews|January 1, 1991
Prospective lung health monitoring in relation to a new power plantA Goren, H Bibi, J R Goldsmith
Journal of Human Nutrition and Dietetics : the Official Journal of the British Dietetic Association|November 15, 2018
Adherence to the Mediterranean diet was positively associated with micronutrient adequacy and negatively associated with dietary energy density among adolescentsW Peng, E M Berry, R Goldsmith
Frontiers of Gastrointestinal Research|January 1, 1979
Gastric cancer incidence: suggestive evidence for persisting effects of experiences during 1940--50 (World War II and Postwar) among Eastern European immigrants to Israel and in Warsaw and rural PolandJ R Goldsmith, R Steinitz, Z Wronkowski
Current Opinion in Oncology|July 26, 2022
Selinexor therapy for multiple myeloma and non-Hodgkin lymphomasScott R Goldsmith, Lawrence Liu, Kevin Shiah
Drugs of Today (Barcelona, Spain : 1998)|November 25, 2021
Isatuximab for the treatment of multiple myelomaS R Goldsmith, L Liu, F Covut
Current Hematologic Malignancy Reports|August 27, 2022
Bispecific Antibodies for the Treatment of Multiple MyelomaScott R Goldsmith, Shawn Streeter, Fahrettin Covut
Pageof 75